Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT02268760
Brief Summary:
To assess the safety, tolerance and pharmacokinetics of 5 mg to 2400 mg BILN 2061 ZW
1. In rising single doses
2. With and without a 64 g fat breakfast at one selected dose
Study:
NCT02268760
Study Brief:
Protocol Section:
NCT02268760